/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
About us
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Brokers Promotions
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
About us
Contact Us
Terms Of Use
Become A Contributer
EUR/USD
-0.14%
Natural Gas
+2.22%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
+0.11%
VIX
N/A
Economic Calendar
EUR/USD
-0.14%
Natural Gas
+2.22%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
+0.11%
VIX
N/A
Economic Calendar
BTC
N/A
ETH
N/A
XRP
N/A
ADA
N/A
SOL
N/A
Review
Review
Review
Key PCE Inflation Gauge Rose 2.8% Annually in February as Expected
about 1 hour ago
Will the PCE Report Derail the Fed’s Anticipated Rate Cut Plans?
about 2 hours ago
The Market News Today: Upcoming PCE Report to Influence Fed’s Rate Decisions
about 3 hours ago
US GDP for Previous Quarter Adjusted Upward to a Robust Annual 3.4%
about 23 hours ago
The Market News Today: US GDP Forecast at 3.2%, Eyes on Fed and Market Response
1 day ago
German Retail Sales Tumble 1.9% in February Driving ECB Rate Cut Bets
1 day ago
Bitcoin Weekly Price Forecast – Bitcoin Continues to Look Bullish
11 minutes ago
US Dollar (DXY) Index News: PCE Data Balances Inflation, Fed Policy Expectations
12 minutes ago
Gold Price Forecast – Gold Waits For Monday
27 minutes ago
EUR/USD Forecast – Euro Finds Support in Thin Markets
31 minutes ago
Bitcoin Price Forecast – Bitcoin Continues to See Consolidation
37 minutes ago
NASDAQ 100 Price Forecast – NASDAQ 100 Continues to Look Bullish
43 minutes ago
Quick Links
:
Forecasts
Economic Calendar
Commodities
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
BIIB
profile
Biogen Inc
Follow
BIIB
(
Nasdaq - US
)
Closed
215.63
-0.71 (-0.33%)
in
:
usd
•
As of: Mar 28, 2024 15:59
UTC -4
After Market
:
215
-0.63 (-0.29%)
Open
217.22
High
217.42
Low
214.00
Overview
News & Analysis
Profile
Financials
Advanced Chart
History
Earnings
About
Biogen Inc
CEO
Christopher A. Viehbacher
Headquarters
225 binney street
cambridge, ma 02142, united states
Auditor
PricewaterhouseCoopers LLP
Employees
7,570
Share Holders
420
Website
www.biogen.com
Industry
pharmaceuticals major
Sector
health technology
Company Overview
Biogen Inc. is one of the world's leading biotechnology companies which focuses on developing innovative therapies for treating serious neurological and neurodegenerative diseases, including its core growth areas of multiple sclerosis (MS) and neuroimmunology, Alzheimer's disease (AD) and dementia, movement disorders including Parkinson's disease, neuromuscular disorders, including spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS) and ophthalmology. Key multiple sclerosis/MS drugs in its portfolio are Tecfidera, Vumerity, Avonex, Plegridy, Fampyra and Tysabri. Other approved/marketed products include Fumaderm (severe psoriasis), Spinraza (spinal muscular atrophy (SMA)) and Aduhelm (Alzheimer's disease).
Biogen Inc
Statistics
Valuation Measures
Market Capitalization
2
31.34B
Enterprise Value
37.23B
Enterprise Value/EBITDA
(ttm)
17.41
Price to Earnings Ratio
(ttm)
14.69
Price to Book
(mrq)
2.12
Price to Sales
(ttm)
3.20
Price to Cash
(ytd)
11.74
Profitability
Gross Margin
(ttm)
74.24%
Operating Margin
(ttm)
21.80%
Profit Margin
(ttm)
11.90%
Return on Equity
(ttm)
14.91%
Return on Invested Capital
(ttm)
5.62%
Return on Assets
(ttm)
8.18%
Income Statement
Revenue
(ttm)
9.84B
Revenue Per Share
(ttm)
67.66
Gross Profit
(ttm)
7.30B
EBITDA
(ttm)
3
2.14B
Net Income Avi to Common
(ttm)
1.16B
Diluted EPS
(ttm)
7.98
Share Statistics
Beta (5Y Monthly)
-0.03
52-Week Change
-21.31%
S&P500 52-Week Change
30.45%
S&P500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding
1
145.36M
Dividend Yield
0.00%
Float
4
144.49M
%
Held by Insiders
0.60%
%
Held by Institutions
87.93%
Balance Sheet
Total Cash
(mrq)
1.05B
Total Cash Per Share
(mrq)
7.22
Total Debt
(mrq)
6.94B
Total Debt/Equity
(mrq)
46.88%
Current Ratio
(mrq)
2.00%
Quick Ratio
(mrq)
1.26%
Book Value Per Share
(mrq)
102.14
Cash Flow
Operating Cash Flow Per Share
(ytd)
10.63
Free Cash Flow
(ytd)
1.27B
Table Key
mrq
=
Most Recent Quarter
ttm
=
Trailing Twelve Months
ytd
=
Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.
1
Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2
Market Cap is calculated using total shares outstanding and the most recent share price.
3
EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4
The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker